Transparency policy

1. Why we publish this

People who volunteer for a study are entitled to know that it was planned in the open and that its results will be shared, whether the medicine worked or not. This page sets out how Westbridge Clinical Studies does both.

2. Registering studies before they start

Each study is registered on ClinicalTrials.gov before the first participant is enrolled. The record names the condition, the study design, what is being measured and where the study is running, and it is kept up to date while the study recruits.

In the United States, registration of most trials of medicines is a legal duty under section 801 of the Food and Drug Administration Amendments Act and its rule, 42 CFR Part 11. We register every study regardless of whether that duty applies.

3. Sharing results

Summary results are posted to the study's registry record within the time the law sets, and we post them for studies the law does not cover as well. Results are published whether they are positive, negative or inconclusive.

Where a study sends participants a summary of what it found, the summary is written in plain language rather than the language of a journal article.

4. Requests for study data

Qualified researchers can ask for anonymized data from completed studies to carry out their own analysis. Each request is reviewed for its scientific purpose and for whether the data can be shared without identifying anyone who took part.

Send a request to info@westbcs.com with the study's registry number and a short description of the research question.

5. What we do not share

Nothing on this page involves releasing anything that names a participant. Study records are coded before they leave the study site, and what we collect through this website is covered by our privacy policy.

6. Questions about this policy

Call (719) 701-8266 or email info@westbcs.com, and we will answer or point you to the registry record you need.